Search details
1.
BRCA gene amplification in primary peritoneal high-grade serous carcinoma patient with intrinsic resistance to platinum treatment: a case report.
Pathologica
; 115(2): 107-110, 2023 Apr.
Article
in English
| MEDLINE | ID: mdl-37114628
2.
Clinicopathologic correlates of first-line pembrolizumab effectiveness in patients with advanced NSCLC and a PD-L1 expression of ≥ 50.
Cancer Immunol Immunother
; 69(11): 2209-2221, 2020 Nov.
Article
in English
| MEDLINE | ID: mdl-32474768
3.
Clinical Outcomes of Patients with Advanced Cancer and Pre-Existing Autoimmune Diseases Treated with Anti-Programmed Death-1 Immunotherapy: A Real-World Transverse Study.
Oncologist
; 24(6): e327-e337, 2019 06.
Article
in English
| MEDLINE | ID: mdl-30796151
4.
Early fatigue in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: an insight from clinical practice.
J Transl Med
; 17(1): 376, 2019 11 15.
Article
in English
| MEDLINE | ID: mdl-31730009
5.
Retinal metastasis regression with eribulin in a heavily pretreated breast cancer patient.
Future Oncol
; 11(15 Suppl): 17-22, 2015.
Article
in English
| MEDLINE | ID: mdl-26235260
6.
Time to strategy failure and treatment beyond progression in pretreated metastatic renal cell carcinoma patients receiving nivolumab: post-hoc analysis of the Meet-URO 15 study.
Front Oncol
; 14: 1307635, 2024.
Article
in English
| MEDLINE | ID: mdl-38410103
7.
Sodium Levels and Outcomes in Patients With Metastatic Renal Cell Carcinoma Receiving Nivolumab.
JAMA Netw Open
; 6(11): e2345185, 2023 Nov 01.
Article
in English
| MEDLINE | ID: mdl-38010650
8.
"Poker" association of weekly alternating 5-fluorouracil, irinotecan, bevacizumab and oxaliplatin (FIr-B/FOx) in first line treatment of metastatic colorectal cancer: a phase II study.
BMC Cancer
; 10: 567, 2010 Oct 19.
Article
in English
| MEDLINE | ID: mdl-20958992
9.
Another side of the association between body mass index (BMI) and clinical outcomes of cancer patients receiving programmed cell death protein-1 (PD-1)/ Programmed cell death-ligand 1 (PD-L1) checkpoint inhibitors: A multicentre analysis of immune-related adverse events.
Eur J Cancer
; 128: 17-26, 2020 03.
Article
in English
| MEDLINE | ID: mdl-32109847
10.
Immune-related Adverse Events of Pembrolizumab in a Large Real-world Cohort of Patients With NSCLC With a PD-L1 Expression ≥ 50% and Their Relationship With Clinical Outcomes.
Clin Lung Cancer
; 21(6): 498-508.e2, 2020 11.
Article
in English
| MEDLINE | ID: mdl-32680806
11.
Late immune-related adverse events in long-term responders to PD-1/PD-L1 checkpoint inhibitors: A multicentre study.
Eur J Cancer
; 134: 19-28, 2020 07.
Article
in English
| MEDLINE | ID: mdl-32454395
12.
Evaluating the role of FAMIly history of cancer and diagnosis of multiple neoplasms in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: the multicenter FAMI-L1 study.
Oncoimmunology
; 9(1): 1710389, 2020.
Article
in English
| MEDLINE | ID: mdl-32002308
13.
Correlations Between the Immune-related Adverse Events Spectrum and Efficacy of Anti-PD1 Immunotherapy in NSCLC Patients.
Clin Lung Cancer
; 20(4): 237-247.e1, 2019 07.
Article
in English
| MEDLINE | ID: mdl-30885550
14.
A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable.
J Immunother Cancer
; 7(1): 57, 2019 02 27.
Article
in English
| MEDLINE | ID: mdl-30813970
15.
Timed-flat infusion of 5-fluorouracil associated with docetaxel as first-line treatment of patients with metastatic breast cancer.
Breast J
; 14(1): 116-7, 2008.
Article
in English
| MEDLINE | ID: mdl-18086273
16.
Effective analgesic score: a "marker" of the effects of chemotherapy on pain in advanced cancer patients?
J Pain Symptom Manage
; 34(4): 339-42, 2007 Oct.
Article
in English
| MEDLINE | ID: mdl-17703911
17.
Modulation of GemOx chemotherapy according to CIRS in elderly patients with advanced pancreatic cancer.
Oncol Rep
; 27(2): 423-32, 2012 Feb.
Article
in English
| MEDLINE | ID: mdl-22020810
18.
Efficacy of pregabalin in the management of cetuximab-related itch.
J Pain Symptom Manage
; 32(5): 397-8, 2006 Nov.
Article
in English
| MEDLINE | ID: mdl-17085262
19.
Phase II study of sorafenib in patients with sunitinib-refractory metastatic renal cell cancer.
J Clin Oncol
; 27(27): 4469-74, 2009 Sep 20.
Article
in English
| MEDLINE | ID: mdl-19652053
Results
1 -
19
de 19
1
Next >
>>